Gil D. Fine
Gil D. Fine publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Hematology, on topics such as Cancer Genomics and Diagnostics, Acute Myeloid Leukemia Research and Colorectal Cancer Treatments and Studies.
- World rank
- #5,845,544 of 7,710,434 ranked researchers
- Rank in United States
- #1,439,652 of 1,627,098
- Works
- 22
- Citations
- 207
- Citations per work
- 9.4
What does Gil D. Fine research?
Gil D. Fine's work is mostly in Medicine (57%), Mathematics (11%), Biochemistry, Genetics and Molecular Biology (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1256.6%
- Medicine1256.6%
- Everything else522.7%
- Physical Sciences211.3%
- Mathematics211.3%
- Life Sciences29.4%
- 1Oncology24% of their works
- 2Pulmonary and Respiratory Medicine13% of their works
- 3Hematology13% of their works
- 4Statistics and Probability11% of their works
- 5Cancer Research9% of their works
- 6Radiology, Nuclear Medicine and Imaging6% of their works
Research topics
Which keywords describe Gil D. Fine's research?
The keywords of their largest research topics: Targeted Therapy, Chemotherapy, Acute Myeloid Leukemia, ALK Inhibitors, AML, Cancer Genomics, Cetuximab and EGFR Mutations.
- Taxanes
- Pancreatic Cancer
- False Discovery Rate
- BCR-ABL
- Mutational Signatures
- EGFR Mutations
- Cancer Genomics
- AML
- Chemotherapy
- Targeted Therapy
- ALK Inhibitors
- Acute Myeloid Leukemia
- Cetuximab
- KRAS Mutations
- Adaptive Designs
- Chemotherapy-Induced Peripheral Neuropathy
- Imatinib
- Surgical Complications
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Targeted Therapy82 topics
- Chemotherapy72 topics
- ALK Inhibitors41 topic
- AML41 topic
- Acute Myeloid Leukemia41 topic
- Cancer Genomics41 topic
- Cetuximab41 topic
- EGFR Mutations41 topic
- KRAS Mutations41 topic
- Mutational Signatures41 topic
- Adaptive Designs31 topic
- BCR-ABL31 topic
- Chemotherapy-Induced Peripheral Neuropathy31 topic
- False Discovery Rate31 topic
- Imatinib31 topic
- Pancreatic Cancer31 topic
- Surgical Complications31 topic
- Taxanes31 topic
Where does Gil D. Fine work?
Gil D. Fine's main affiliation in the publication record is Sumitomo Dainippon Pharma (United States), United States.
How many publications and citations does Gil D. Fine have?
OpenAlex counts 22 works and 207 citations for Gil D. Fine, an h-index of 7, ranking #5,845,544 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Gil D. Fine. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.